Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

payer survey

- PMLiVE

Why patients ignore your trials – how to make clinical trials stand out in the real world among the world’s biggest brands

By Mark Evans and Angelina Radjenovic

Embracing Vulnerability in Virtual Leadership – Building Company Culture Virtually

Leadership is about more than guidance—it's about vulnerability. Learn how being genuine and approachable can foster trust and open communication, creating a psychologically safe space for your team to thrive....

Impetus Digital

- PMLiVE

Making an Impact at the Agents of Change Summit

Medscape Public Health is hitting the road to attend the public health conference Agents of Change. As part of their commitment to making an impact in public health, Medscape is...

Medscape Education

Biogen Idec building

Biogen gains rights to Stoke’s Dravet syndrome candidate in deal worth $550m

The rare genetic epilepsy affects up to 38,000 people in the US, UK, EU and Japan

- PMLiVE

FDA grants RMAT designation to AskBio’s Parkinson’s gene therapy candidate

The progressive neurodegenerative disease affects more than ten million people worldwide

- PMLiVE

EC approves CSL/Arcturus’ self-amplifying mRNA COVID-19 vaccine Kostaive

Kostaive is designed to instruct the body to make more mRNA to boost immune response

- PMLiVE

Inclusivity, collaboration and targeted care

The challenge of achieving inclusivity for ethnic minorities and women in clinical trials

- PMLiVE

Amplifying Women’s Voices in Healthcare: Medscape Education’s Award-Winning Podcast Series

“Be the change you want to see in the world.” Though the origins of this quote are a little fuzzy, the idea is crystal clear, and can inspire you to...

Medscape Education

- PMLiVE

Humanizing Healthcare & Medical Education: The Power of Patient Integration

True ‘patient-centricity’ goes beyond treating disease—it means ensuring that patient voices shape research, decision-making, and medical education. We are in the era of Patient Integration, where the patient voice is...

Medscape Education

- PMLiVE

Merck’s Welireg granted EC approval for von Hippel-Lindau disease and kidney cancer

Up to 15,000 people in Europe are living with VHL, a rare tumour-causing genetic disease

- PMLiVE

Sanofi and Regeneron’s Dupixent granted FDA priority review for bullous pemphigoid

Approximately 27,000 adults in the US are living with uncontrolled cases of the skin disease

- PMLiVE

AstraZeneca shares promising phase 3 results for Imfinzi in bladder cancer

More than 614,000 people are diagnosed with bladder cancer globally every year

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links